As a putative proto-oncogene for GBY and cell cycle regulator, TSPY expression in somatic cancers could play key roles in various male biases in incidence, progression, and treatment responses among the positive tumors, particularly HCC [21]. The gene discussed is TSPY1; the disease is hepatocellular carcinoma.